Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.50 |
| ▸ | XDH | P47989 | 6/20 | 0.49 |
| ▸ | MGLL | Q99685 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.42 |
| ▸ | TLR4 | O00206 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL257218 | 1.00 | CTSL (0.55) | CTSLKDM4ESMN1; SMN2CTBP2XDH | |
| SCHEMBL4586154 | 1.00 | CTSL (0.55) | CTSLKDM4ESMN1; SMN2CTBP2XDH | |
| SCHEMBL8407033 | 0.88 | MGLL (0.58) | CTSLKDM4ESMN1; SMN2CTBP2XDH | |
| SCHEMBL28302059 | 0.88 | LMNA (0.52) | CTSLKDM4ESMN1; SMN2CTBP2XDH | |
| SCHEMBL4586342 | 0.86 | ALDH1A1 (0.51) | CTSLKDM4ESMN1; SMN2CTBP2XDH | |
| SCHEMBL9324776 | 0.86 | KDM4E (0.46) | CTSLKDM4ESMN1; SMN2CTBP2XDH | |
| SCHEMBL9324768 | 0.86 | KDM4E (0.46) | CTSLKDM4ESMN1; SMN2CTBP2XDH | |
| SCHEMBL9321485 | 0.86 | GAA (0.50) | CTSLKDM4ESMN1; SMN2CTBP2XDH | |
| SCHEMBL4587535 | 0.86 | SMN1; SMN2 (0.50) | CTSLKDM4ESMN1; SMN2CTBP2XDH | |
| SCHEMBL13853886 | 0.86 | KDM4E (0.54) | CTSLKDM4ESMN1; SMN2CTBP2XDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118638503-A | Reusable polyurethane hot melt adhesive containing multiple dynamic covalent bond crosslinking and preparation method and application thereof | 浙江禾欣科技有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-116334785-A | Method for preparing covalent cross-linked fiber from covalent adaptive network | 东华大学 | 2023-06-27 | — | — | CN | claimed |
| CN-112479997-B | Synthetic method of 2, 3-diphenylquinoline | 湖南工程学院 | 2022-02-08 | — | — | CN | claimed |
| CN-112830913-A | Method for preparing 2, 5-furan diformylaldoxime | 中国科学院宁波材料技术与工程研究所 | 2021-05-25 | — | — | CN | claimed |
| CN-103172583-A | Parecoxib preparation method | SHENZHEN JIFU PHARMACEUTICAL CO LTD | 2013-06-26 | — | — | CN | claimed |
| CN-101412666-B | Method for preparing carbonyl compound by catalytic oxidation of oxime | UNIV SUN YAT SEN | 2011-05-04 | — | — | CN | claimed |
| EP-1527165-A4 | A RHODOCOCCUS GENE ENCODING ALDOXIME DEHYDRATASE | DU PONT (US) | 2006-06-07 | — | — | EP | claimed |
| EP-1527165-A2 | A RHODOCOCCUS GENE ENCODING ALDOXIME DEHYDRATASE | E.I. du Pont de Nemours and Company (US) | 2005-05-04 | — | — | EP | claimed |
| EP-1438300-A1 | METHOD FOR PREPARING BENZENESULFONYL COMPOUNDS | Pharmacia Corporation (US) | 2004-07-21 | — | — | EP | claimed |
| WO-2003078581-A2 | A RHODOCOCCUS GENE ENCODING ALDOXIME DEHYDRATASE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-09-25 | — | — | WO | claimed |
| US-20030105334-A1 | Method for preparing benzenesulfonyl compounds | LETENDRE LEO J (US) | 2003-06-05 | — | — | US | claimed |
| WO-2003029230-A1 | METHOD FOR PREPARING BENZENESULFONYL COMPOUNDS | PHARMACIA CORPORATION (US) | 2003-04-10 | — | — | WO | claimed |
| US-4327222-A | REACTING AN ARYL SUBSTITUTED KETONE WITH HYDROXYLAMINE TO FORM OXIME, THEN CYCLIZATION WITH BUTYLLITHIUM | CDC LIFE SCIENCES INC. (CA) | 1982-04-27 | — | — | US | claimed |
| EP-0026928-A1 | 3,4-Diarylisoxazol-5-acetic acid compounds, process for preparing the same, and pharmaceuticals containing the same | CDC Life Sciences Inc. (CA) | 1981-04-15 | — | — | EP | claimed |
| JP-62270567-A | — | — | None | — | — | JP | disclosed |
| CN-118638503-A | Reusable polyurethane hot melt adhesive containing multiple dynamic covalent bond crosslinking and preparation method and application thereof | 浙江禾欣科技有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-115160962-B | Anaerobic sealant and preparation method thereof | 硕德半导体技术(苏州)有限公司 | 2024-01-26 | — | — | CN | disclosed |
| US-4194050-A | HYDROGENATING OXIMES HAVING AN ALPHA-HYDROGEN USING A RUTHENIUM CATALYST AND A CARBOXYLIC ANHYDRIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-03-18 | — | — | US | disclosed |
| US-4190656-A | VIRICIDES, ANTITUMOR AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1980-02-26 | — | — | US | disclosed |
| US-4137417-A | Process for producing an enamide | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1979-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105334-A1 | Method for preparing benzenesulfonyl compounds | TST, PTGS2, STS | CTSL 2598/4885KDM4E 877/4885SMN1; SMN2 2104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.